SEATTLE--(BUSINESS WIRE)--Parse Biosciences GigaLab to support the Icahn School of Medicine at Mount Sinai in generating a large Alzheimer's and...
Vous n'êtes pas connecté
Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass, and combined with a GLP-1 agonist like Ozempic, increased it by 700%. The team discovered that alpha cells could potentially be transformed into beta cells, offering a new source for insulin production.
SEATTLE--(BUSINESS WIRE)--Parse Biosciences GigaLab to support the Icahn School of Medicine at Mount Sinai in generating a large Alzheimer's and...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences GigaLab to support the Icahn School of Medicine at Mount Sinai in generating a large Alzheimer's and...
Some cases of pancreatitis reported to be linked to GLP-1 medicines have been fatal.
The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.
The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.
According to recent research data, most Americans remain unaware of CAR T-cell therapy, which represents a revolutionary medlinkcancer/medlink...
An international team of scientists just delivered a major breakthrough in diabetes research by successfully 3D printing functional human islets using...
An international team of scientists just delivered a major breakthrough in diabetes research by successfully 3D printing functional human islets using...
A new type of diabetes pill has been shown to act in a similar way to injectable treatments like Ozempic, with more like it in the pipeline.
A new type of diabetes pill has been shown to act in a similar way to injectable treatments like Ozempic, with more like it in the pipeline.